WHITEHAWK THERAPEUTICS, INC. Payments of Financing Costs
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Payments of Financing Costs of $90.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2026-08-06
- WHITEHAWK THERAPEUTICS, INC. payments of financing costs for the quarter ending 2025-12-31 was $0.00.
- WHITEHAWK THERAPEUTICS, INC. payments of financing costs for the quarter ending 2025-09-30 was $0.00.
- WHITEHAWK THERAPEUTICS, INC. payments of financing costs for the quarter ending 2025-06-30 was $76.00K, a 985.71% increase year-over-year.
- WHITEHAWK THERAPEUTICS, INC. payments of financing costs for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. payments of financing costs for fiscal 2025 was $76.00K, a 375.00% increase from fiscal 2024.
- WHITEHAWK THERAPEUTICS, INC. payments of financing costs for fiscal 2024 was $16.00K, a 90.00% decline from fiscal 2023.
- WHITEHAWK THERAPEUTICS, INC. payments of financing costs for fiscal 2023 was $160.00K, a 52.52% decline from fiscal 2022.
- WHITEHAWK THERAPEUTICS, INC. payments of financing costs for fiscal 2022 was $337.00K.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month | Payments of Financing Costs 9 month | Payments of Financing Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $90.00K 10-Q · filed 2026-08-06 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $76.00K derived: sum of 3 quarters · filed 2026-08-06 | $76.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $76.00K derived: sum of 2 quarters · filed 2026-08-06 | $76.00K 10-Q · filed 2025-11-06 | $75.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $76.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $76.00K 10-Q · filed 2026-08-06 | $75.00K derived: sum of 3 quarters · filed 2026-08-06 | $75.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | -$1.00K derived: sum of 2 quarters · filed 2026-03-12 | -$1.00K derived: sum of 3 quarters · filed 2026-03-12 | $6.00K derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$1.00K derived: sum of 2 quarters · filed 2026-03-12 | $6.00K derived: sum of 3 quarters · filed 2026-03-12 | $16.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $7.00K derived: sum of 2 quarters · filed 2025-11-06 | $17.00K 10-Q · filed 2025-11-06 | $51.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $17.00K 10-Q · filed 2025-08-07 | $51.00K derived: sum of 3 quarters · filed 2025-08-07 | $128.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $10.00K 10-Q · filed 2025-05-08 | $44.00K derived: sum of 2 quarters · filed 2025-05-08 | $121.00K derived: sum of 3 quarters · filed 2025-05-08 | $170.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $111.00K derived: sum of 2 quarters · filed 2025-03-28 | $160.00K derived: sum of 3 quarters · filed 2025-03-28 | $160.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | $77.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $126.00K derived: sum of 2 quarters · filed 2024-11-06 | $126.00K 10-Q · filed 2024-11-06 | $240.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $49.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $49.00K 10-Q · filed 2024-08-07 | $163.00K derived: sum of 3 quarters · filed 2024-08-07 | $163.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-08 | $114.00K derived: sum of 2 quarters · filed 2024-05-08 | $114.00K derived: sum of 3 quarters · filed 2024-05-08 | |
| 2022-12-31 | $114.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $114.00K derived: sum of 2 quarters · filed 2024-03-13 | $337.00K 10-K · filed 2024-03-13 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $223.00K 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | $223.00K 10-Q · filed 2023-08-09 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $0.00 10-K · filed 2023-03-29 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |